UnitedHealth included gains from asset sales in its adjusted earnings — a move that’s allowed but now has some analysts ...

Tariffs and FDA layoffs have investors focusing on later-stage companies.

Providers are touting PACE as a lower-cost alternative to nursing homes as states grapple with deep cuts to federal Medicaid funding.

In October, Modern Healthcare will reveal the ranked order of the 2025 Best Places to Work in Healthcare.

States and hospitals will have to absorb $1.3 trillion in Medicaid funding cuts over the next decade.

The Senate advanced President Donald Trump’s tax-cut bill Tuesday with provisions that are estimated to slash healthcare spending by well over $1 trillion, with most of it coming from Medicaid.

Health insurance exchange carriers are mulling four scenarios — and substantial premium increases — for 2026.

Value-based care platform Astrana Health acquired some of Prospect Health’s assets Tuesday for $708 million.

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the highly popular medications.

A recent competition at the Connecticut health system highlighted how artificial intelligence is helping physicians turn clinical insights into innovation.

Welsh, Carson, Anderson & Stowe made an unspecified investment in Constitution Surgery Alliance, an ambulatory surgery center operator with growth plans.

The Health Resources and Services Administration has overseen the 340B Drug Pricing Program since its creation in 1992. That could change soon.